Accenture Chief Executive Officer (CEO) Julie Sweet has disclosed a health update in an internal mail to employees. The CEO has been diagnosed with early-stage breast cancer, with treatment expected ...

Accenture CEO Julie Sweet was praised this week for her openness regarding a breast cancer diagnosis, which also gave rare insight into how executives disclose their life-altering health news.

Julie Spellman Sweet, Chair and CEO of Accenture plc (NYSE:ACN), recently sold a significant portion of her holdings in the company. According to a regulatory filing, Sweet disposed of 7,793 Class ...

Good morning. Accenture CEO Julie Sweet announced yesterday that her breast cancer has come back, noting in a memo to staff that “the prognosis from my doctor is excellent; the cancer was caught ...

Accenture CEO Julie Sweet has been diagnosed with early-stage breast cancer and the treatment is likely to last 12-16 weeks, according to a Moneycontrol report. However, the CEO will continue to ...